Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
about
The structural biology of enzymes involved in natural product glycosylationMolecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin ResistanceResistance to antibiotics targeted to the bacterial cell wallCloning, expression and characterization of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Wolbachia endosymbiont of human lymphatic filarial parasite Brugia malayiAntimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland ChinaSurveillance of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Dairy Cattle Farms in the Nile Delta, EgyptThe effect of MEP pathway and other inhibitors on the intracellular localization of a plasma membrane-targeted, isoprenylable GFP reporter protein in tobacco BY-2 cellsAssessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.Mutations of the Transporter Proteins GlpT and UhpT Confer Fosfomycin Resistance in Staphylococcus aureus.Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymesIdentification of a novel fosfomycin-resistant UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from a soil metagenome.First report of a clinical, multidrug-resistant Enterobacteriaceae isolate coharboring fosfomycin resistance gene fosA3 and carbapenemase gene blaKPC-2 on the same transposon, Tn1721.Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases.Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii.Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in TaiwanDissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China.Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: MurA confers clinical resistance at low fitness costPrevalence of Fosfomycin Resistance and Mutations in murA, glpT, and uhpT in Methicillin-Resistant Staphylococcus aureus Strains Isolated from Blood and Cerebrospinal Fluid Samples.A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans.Molecular Basis for Resistance Against Phosphonate Antibiotics and Herbicides.FosfomycinUncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic AspectsFosfomycin: Resurgence of an old companion.Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions.UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments.Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model.Fosfomycin: Mechanism and Resistance.Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.Cooperative Actions of CRP-cAMP and FNR Increase the Fosfomycin Susceptibility of Enterohaemorrhagic Escherichia coli (EHEC) by Elevating the Expression of glpT and uhpT under Anaerobic Conditions.Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates.High prevalence of fosfomycin resistance gene fosA3 in bla CTX-M-harbouring Escherichia coli from urine in a Chinese tertiary hospital during 2010-2014.Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.Identification of a second two-component signal transduction system that controls fosfomycin tolerance and glycerol-3-phosphate uptake.Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli.Role of the CpxAR two-component signal transduction system in control of fosfomycin resistance and carbon substrate uptake.Importation of Fosfomycin Resistance fosA3 Gene to Europe.Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus.Clonal diversity of Escherichia coli isolates carrying plasmid-mediated fosfomycin resistance gene fosA3 from livestock and other animals.
P2860
Q26824482-8E9DAF7E-7D23-4E0E-86BD-23A8976DD262Q26853135-BE2672F6-DACB-4B6A-AA3E-B97C7C5F4202Q26859841-2AA21A4A-D61F-4F3B-B20C-434DD0EA4EDFQ28539823-32C0542E-819D-479B-9397-5B865148B0BBQ28547100-D9CDEBDB-0AE2-4096-B918-F17BEA2066E3Q28596830-EA6460EA-69D9-455E-A9B2-91FE56C2ADFAQ28660742-DE8DE1C6-1D10-4FEC-B908-E37FC567972AQ33564290-F4A7291C-03B6-410C-9F0B-F37CC717F57CQ33707109-1974D315-A13E-47BB-B8D1-A000DD28E8ECQ33962732-8E22E69A-A5A6-4F95-88F4-86E44C33217EQ34473355-5FE8014C-C570-4831-9EAB-ACA172226B43Q34922505-B7A01599-FF58-4119-91D2-0CE31B0438ABQ35035695-83B1B64C-6747-43BA-9C73-D3E323CBF7E7Q35102319-64E7928C-A259-481B-BB00-6F271F085FB1Q35747796-480FC23A-41C1-43F9-BA53-F732AE5A41AEQ35867426-FEC746FC-B45A-4BDD-80F3-A856ACCFEE1CQ35941216-BED43733-0B9D-445A-B0B9-8CBFAA9CD6F3Q36448220-892ABCC4-9905-4FFE-8116-5ACE02EB0702Q36472903-4F85C78E-E406-4409-A062-F16657FF07B4Q36490822-55BF20A0-8098-40C8-87C3-BFA85B424328Q36675246-61178747-3946-4A46-B359-69D489B8B892Q36683661-BAA000E8-F738-4E3E-9F90-D4F953FEE05CQ36803694-576CBC91-FDCA-4343-A935-D0916DC323B5Q37263313-077B44F7-2767-4884-9B39-5C849921ACE7Q37913126-2E4278A5-4FD0-4C8B-A214-5747EBF7226FQ37957839-31D850D8-2A59-42D9-909E-7E1A6FEC3C42Q38689344-7C431830-8C45-4F60-A79D-6427E4C33C26Q38725968-D45618F6-A66D-4F55-BAFE-8648456AFBD7Q39071416-8CBBA7C1-D353-484B-A9CE-91DAF8E0F0FFQ39361363-836226CA-342B-478A-BACC-07D9E688F584Q40271215-1CFBA5FE-4647-42B4-9C1A-BD674767B6D9Q40333130-EF8D4BB6-6A5F-4767-853B-3F25FAFF6662Q40415709-39D0E7C8-2BB6-469D-BD80-FE58D5E12A72Q41066081-06A608A1-EB78-4AC7-9F8E-B27BFDFFF422Q41597001-EF7FC7C2-272D-42FB-9271-8A6B79AFB6A2Q41639665-4BE43F4F-2048-4AAB-BAA2-38C3427BA17EQ41908390-58E7DB2C-39A7-4FCB-AA0F-F5ECEF53B5D7Q42539277-60FA9E01-107F-43CA-AB3E-412922FB7C5EQ42582994-B2C176AA-887C-4024-ADA4-CC37CA38DD0FQ42797063-67EF2CC9-1F21-4F59-953F-A0374EEC8E72
P2860
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
@en
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
@nl
type
label
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
@en
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
@nl
prefLabel
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
@en
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
@nl
P2093
P1476
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli.
@en
P2093
Chikara Nakahama
Kazunori Maebashi
Kazunori Tomono
Shinichi Terada
Shiro Sakakibara
Sho Takahata
Takashi Ida
Tetsuro Matsumoto
Tetsuro Muratani
Toru Hiraishi
P304
P356
10.1016/J.IJANTIMICAG.2009.11.011
P577
2010-01-13T00:00:00Z